The research for Managing IP Awards and IP STARS rankings 2024

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

The research for Managing IP Awards and IP STARS rankings 2024

2024 research edition.jpg

Firms are invited to participate in the research for the 2024 edition of the Managing IP Awards programme and IP STARS rankings

Managing IP's research team has commenced research for the 2024 edition of the IP STARS rankings and Managing IP Awards programme. The research comprises analysis of submissions, market feedback from interviews and surveys, and independent desk research.

We will host a webinar (see below) on September 14, 2023, to provide information about the research and how to participate.

Law firm submissions

The most important way for firms to participate in our research is to submit their firm questionnaire and client referee documents each year. We use the submissions for the firm and practitioner rankings and the Managing IP Awards programme.

The research documents

Firms need to complete the firm questionnaire and two spreadsheets, if required, for referees.

Click here to download the firm questionnaire

Click here to download the in-house referees spreadsheet

Click here to download the private practice referees spreadsheet

The submission deadline is October 31, 2023.

The submission portal

We have a portal for accepting submissions from firms. This proprietary portal allows users to create accounts, submit their research documents, and have access to them in the future.

Access the portal here.

Register to listen to our webinar

Register for our webinar to get guidance on completing our research forms and using the portal. The user guide for the portal can be found here.

About IP STARS

IP STARS is an exclusive rankings publication which recognises the leading firms and practitioners for intellectual property work. The research covers several IP practice areas and more than 70 jurisdictions, making it the most comprehensive and widely respected guide in the IP profession.

Managing IP published its first legal directory in 1994 and rebranded it in 2013 as IP STARS. Read more about the rankings here.

About the Managing IP Awards

The Managing IP Awards programme, which was established in 2006, is the leading IP law firm awards event in the legal industry. The research covers several IP practice areas and more than 50 jurisdictions. Read about the awards programme here.

more from across site and SHARED ros bottom lb

More from across our site

Not all private equity firms are the same, so leaders at four externally backed IP firms came together to discuss the frameworks they followed and how they ensured a cultural fit
Top-tier German and Spanish firms are among the advisers on a Europe-wide copyright and licensing tussle concerning the design of the track circuit in Madrid
Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
Gift this article